Chronic Kidney Disease and Outcomes in Heart Failure With Preserved Versus Reduced Ejection Fraction: The Cardiovascular Research Network PRESERVE Study

Background— There is scant evidence on the effect that chronic kidney disease (CKD) confers on clinically meaningful outcomes among patients with heart failure with preserved left ventricular ejection fraction (HF-PEF). Methods and Results— We identified a community-based cohort of patients with HF. Electronic medical record data were used to divide into HF-PEF and reduced left ventricular EF on the basis of quantitative and qualitative estimates. Level of CKD was assessed by estimated glomerular filtration rate (eGFR) and by dipstick proteinuria. We followed patients for a median of 22.1 months for outcomes of death and hospitalization (HF-specific and all-cause). Multivariable Cox regression estimated the adjusted relative-risk of outcomes by level of CKD, separately for HF-PEF and HF with reduced left ventricular EF. We identified 14 579 patients with HF-PEF and 9762 with HF with reduced left ventricular EF. When compared with patients with eGFR between 60 and 89 mL/min per 1.73 m2, lower eGFR was associated with an independent graded increased risk of death and hospitalization. For example, among patients with HF-PEF, the risk of death was nearly double for eGFR 15 to 29 mL/min per 1.73 m2 and 7× higher for eGFR<15 mL/min per 1.73 m2, with similar findings in those with HF with reduced left ventricular EF. Conclusions— CKD is common and an important independent predictor of death and hospitalization in adults with HF across the spectrum of left ventricular systolic function. Our study highlights the need to develop new and effective interventions for the growing number of patients with HF complicated by CKD.

[1]  Vl Roger,et al.  American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update : a report from the American Heart Association , 2011 .

[2]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.

[3]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Michael K Gould,et al.  Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. , 2012, The Permanente journal.

[5]  M. Greenlick,et al.  Health care research in an HMO : two decades of discovery , 1988 .

[6]  H. Tsutsui [Candesartan in heart failure: assessment of reduction in mortality and morbidity]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[7]  Ali Ahmed,et al.  Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. , 2007, The American journal of cardiology.

[8]  Salim Yusuf,et al.  Predictors of mortality and morbidity in patients with chronic heart failure. , 2006, European heart journal.

[9]  M. Woodward,et al.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.

[10]  R. Garrick,et al.  Chronic Renal Dysfunction as an Independent Risk Factor for the Development of Cardiovascular Disease , 2005, Cardiology in review.

[11]  Stephan von Haehling,et al.  Cachexia as a major underestimated and unmet medical need: facts and numbers , 2010, Journal of cachexia, sarcopenia and muscle.

[12]  M. Bastos,et al.  Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure , 2009, BMC nephrology.

[13]  Hans L. Hillege,et al.  Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.

[14]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[15]  P. Parfrey,et al.  Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management. , 2005, Cardiology clinics.

[16]  N. Uriel,et al.  Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome , 2012, Heart Failure Reviews.

[17]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[18]  A. Collins Cardiovascular Mortality in End-Stage Renal Disease , 2003, The American journal of the medical sciences.

[19]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[20]  A. Go,et al.  Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study , 2006, Circulation.

[21]  D. DeMets,et al.  Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE) , 2011, Circulation. Heart failure.

[22]  D G Altman,et al.  Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. , 1994, Statistics in medicine.

[23]  R. Poveda,et al.  Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  Kdoqi Disclaimer K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  R. Klein,et al.  Prevalence and risk indicators of visual impairment and blindness in Latinos: the Los Angeles Latino Eye Study. , 2004, Ophthalmology.

[26]  W. Aronow,et al.  Increased Prevalence of Coronary Artery Disease, Silent Myocardial Ischemia, Complex Ventricular Arrhythmias, Atrial Fibrillation, Left Ventricular Hypertrophy, Mitral Annular Calcium, and Aortic Valve Calcium in Patients With Chronic Renal Insufficiency , 2006, Cardiology in review.

[27]  P. Iversen,et al.  Decreased hematopoiesis in bone marrow of mice with congestive heart failure. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[29]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[30]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[31]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[32]  A. Rigby,et al.  Mortality at Low and High Estimated Glomerular Filtration Rate Values: A ‘U’ Shaped Curve , 2008, Nephron Clinical Practice.

[33]  G. Breithardt,et al.  Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis. , 2007, International journal of cardiology.

[34]  A. Garg,et al.  Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.